Annual Working Capital
-$21.59 M
-$50.19 M-175.53%
September 30, 2024
Summary
- As of February 26, 2025, CTXR annual working capital is -$21.59 million, with the most recent change of -$50.19 million (-175.53%) on September 30, 2024.
- During the last 3 years, CTXR annual working capital has fallen by -$90.43 million (-131.37%).
- CTXR annual working capital is now -131.37% below its all-time high of $68.83 million, reached on September 30, 2021.
Performance
CTXR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$26.48 M
-$4.88 M-22.62%
December 31, 2024
Summary
- As of February 26, 2025, CTXR quarterly working capital is -$26.48 million, with the most recent change of -$4.88 million (-22.62%) on December 31, 2024.
- Over the past year, CTXR quarterly working capital has stayed the same.
- CTXR quarterly working capital is now -123.36% below its all-time high of $113.34 million, reached on June 30, 2021.
Performance
CTXR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CTXR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -175.5% | 0.0% |
| 3 y3 years | -131.4% | 0.0% |
| 5 y5 years | -747.7% | 0.0% |
CTXR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -131.4% | at low | -143.7% | at low |
| 5 y | 5-year | -131.4% | at low | -123.4% | at low |
| alltime | all time | -131.4% | at low | -123.4% | at low |
Citius Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -$26.48 M(+22.6%) |
| Sep 2024 | -$21.59 M(-175.5%) | -$21.59 M(-190.5%) |
| Jun 2024 | - | $23.85 M(+37.1%) |
| Mar 2024 | - | $17.40 M(-23.1%) |
| Dec 2023 | - | $22.63 M(-20.8%) |
| Sep 2023 | $28.59 M(-28.6%) | $28.59 M(-19.1%) |
| Jun 2023 | - | $35.32 M(+23.1%) |
| Mar 2023 | - | $28.69 M(-24.1%) |
| Dec 2022 | - | $37.78 M(-5.6%) |
| Sep 2022 | - | $40.03 M(-13.7%) |
| Sep 2022 | $40.03 M(-41.8%) | - |
| Jun 2022 | - | $46.37 M(-14.5%) |
| Mar 2022 | - | $54.24 M(-10.5%) |
| Dec 2021 | - | $60.60 M(-12.0%) |
| Sep 2021 | $68.83 M(+596.3%) | $68.83 M(-39.3%) |
| Jun 2021 | - | $113.34 M(+11.1%) |
| Mar 2021 | - | $101.99 M(+4921.2%) |
| Dec 2020 | - | $2.03 M(-79.5%) |
| Sep 2020 | $9.88 M(+196.5%) | $9.88 M(+99.3%) |
| Jun 2020 | - | $4.96 M(+287.2%) |
| Mar 2020 | - | $1.28 M(-261.2%) |
| Dec 2019 | - | -$794.50 K(-123.8%) |
| Sep 2019 | $3.33 M(-51.5%) | $3.33 M(+541.7%) |
| Jun 2019 | - | $519.60 K(-550.7%) |
| Mar 2019 | - | -$115.30 K(-103.6%) |
| Dec 2018 | - | $3.19 M(-53.6%) |
| Sep 2018 | $6.88 M | $6.88 M(+966.8%) |
| Jun 2018 | - | $644.50 K(-74.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $2.51 M(-48.4%) |
| Dec 2017 | - | $4.86 M(+409.3%) |
| Sep 2017 | $955.20 K(-122.3%) | $955.20 K(-110.1%) |
| Jun 2017 | - | -$9.42 M(+34.5%) |
| Mar 2017 | - | -$7.00 M(+20.1%) |
| Dec 2016 | - | -$5.83 M(+35.8%) |
| Sep 2016 | -$4.29 M(+569.8%) | -$4.29 M(+51.5%) |
| Jun 2016 | - | -$2.83 M(+393.7%) |
| Mar 2016 | - | -$573.80 K(-64.0%) |
| Dec 2015 | - | -$1.60 M(+149.0%) |
| Sep 2015 | -$640.70 K(-14.3%) | -$640.70 K(-46.0%) |
| Jun 2015 | - | -$1.19 M(+28.4%) |
| Mar 2015 | - | -$923.40 K(+11.4%) |
| Dec 2014 | - | -$829.00 K(+10.9%) |
| Sep 2014 | -$747.30 K(+4983.7%) | -$747.30 K(+2279.9%) |
| Jun 2014 | - | -$31.40 K(+25.1%) |
| Mar 2014 | - | -$25.10 K(+67.3%) |
| Dec 2013 | - | -$15.00 K(+2.0%) |
| Sep 2013 | -$14.70 K(-68.0%) | -$14.70 K(-76.3%) |
| Jun 2013 | - | -$62.00 K(+7.8%) |
| Mar 2013 | - | -$57.50 K(+21.6%) |
| Dec 2012 | - | -$47.30 K(+3.1%) |
| Sep 2012 | -$45.90 K(+92.1%) | -$45.90 K(+13.6%) |
| Jun 2012 | - | -$40.40 K(+20.2%) |
| Mar 2012 | - | -$33.60 K(+27.3%) |
| Dec 2011 | - | -$26.40 K(+10.5%) |
| Sep 2011 | -$23.90 K | -$23.90 K(+13.8%) |
| Jun 2011 | - | -$21.00 K |
FAQ
- What is Citius Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual working capital year-on-year change?
- What is Citius Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly working capital year-on-year change?
What is Citius Pharmaceuticals annual working capital?
The current annual working capital of CTXR is -$21.59 M
What is the all time high annual working capital for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual working capital is $68.83 M
What is Citius Pharmaceuticals annual working capital year-on-year change?
Over the past year, CTXR annual working capital has changed by -$50.19 M (-175.53%)
What is Citius Pharmaceuticals quarterly working capital?
The current quarterly working capital of CTXR is -$26.48 M
What is the all time high quarterly working capital for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly working capital is $113.34 M
What is Citius Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, CTXR quarterly working capital has changed by $0.00 (0.00%)